Medical tech company Otolith labs announced that it has raised a $20 million series A round to accelerate the development and commercialization of its prescription wearable device geared towards treating chronic vertigo.
Medical tech company Otolith labs announced that it has raised a $20 million series A round to accelerate the development and commercialization of its prescription wearable device geared towards treating chronic vertigo.
No comments:
Post a Comment